Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy

LePage, G. A.; Kaneko, Takeo

Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy^¹

G. A. LePage;

G. A. LePage

Life Sciences Research, Stanford Research Institute

Menlo Park, California 94025

Search for other works by this author on:

This Site

PubMed

Google Scholar

Takeo Kaneko

Life Sciences Research, Stanford Research Institute

Menlo Park, California 94025

Search for other works by this author on:

This Site

PubMed

Google Scholar

Online Issn: 1538-7445

Print Issn: 0008-5472

1970

Cancer Research, Inc.

Cancer Res (1969) 29 (12): 2314–2318.

This work was supported in part by USPHS Research Grant No. CA 10938 from the NIH. Data presented in Tables 1 and 3 were generated in work supported by Contract No. PH43-65-575 with the Cancer Chemotherapy National Service Center, National Cancer Institute, NIH.

This content is only available via PDF.

1970

Cancer Research, Inc.

Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy^¹

Article PDF first page preview

Citing articles via

Email alerts

AACR Journals

Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy1

Article PDF first page preview

Citing articles via

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy^¹